RESUMO
To study the changes in serum and salivary testosterone in rheumatoid arthritis [RA] patients and their implication on bone mineral density [BMD] and bone turnover markers. The above mentioned hormonal levels were measured in fifty post-menopausal RA women [thirty patients with glucocorticoid therapy and twenty treated with other drugs]. Bone turnover markers were also assessed namely Carboxy terminal cross linked telopeptide of type I collagen [ICTP] and carboxy terminal propeptide of type I procollagen [PICP] as well as their relation to BMD was assessed. Although serum and salivary testosterone were higher than controls, there was no significant difference between patients and controls. We observed significantly lower salivary testosterone level in RA on steroids as compared to those not taking steroids. Also salivary testosterone correlated with lumbar BMD and inversely with ICTP